SultanK
Nov 18, 6:33 AM
$ABCL CEO on linkedin.com
Bruce Booth at Atlas does a terrific annual rundown on what’s happening in biotech.
Exciting to see AbCellera ’s ABCL635, a first-in-class antibody treatment for VMS (hot flashes) called out as one of 2026’s six most exciting new drugs. We couldn’t agree more(!) and see tremendous potential for a major breakthrough treatment in women’s health.
And also very proud to see Xenon Pharmaceuticals Inc.’s Azatukelner, a Kv1.7 activator for focal seizures, named right beside us on the list. Congrats Ian Mortimer and the X-team!
And, just case you weren’t watching, Vancouver is slowly but surely proving that we are a world-class center for innovation in drug development. 🇨🇦
Check out the full report here:
https://lnkd.in/grVzDGRN
0 replies